H.R. 5853 (112th): Gray Market Drug Reform and Transparency Act of 2012

May 22, 2012 (112th Congress, 2011–2013)
Died (Referred to Committee)
Elijah Cummings
Representative for Maryland's 7th congressional district
Read Text »
Last Updated
May 22, 2012
11 pages
Related Bills
H.R. 1958 (113th) was a re-introduction of this bill in a later Congress.

Referred to Committee
Last Action: May 14, 2013


This bill was introduced on May 22, 2012, in a previous session of Congress, but was not enacted.

Introduced May 22, 2012
Referred to Committee May 22, 2012
Full Title

To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce.


No summaries available.


House Energy and Commerce


The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Gray Market Drug Reform and Transparency Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to:
(1) make it a prohibited act and a misbranding for a wholesale distributor of prescription drugs to purchase or receive a prescription drug from a pharmacy or a pharmacist,
(2) require annual reporting by wholesale distributors of prescription drugs,
(3) require the Secretary of Health and Human Services (HHS) to establish and maintain a national database of information reported by wholesale distributors of prescription drugs and to require such database to include information on actions taken by states against wholesale distributors (e.g., disciplinary actions and license revocations),
(4) require the Secretary to assess and collect fees from wholesale distributors of prescription drugs, and
(5) require wholesale distributors of prescription drugs to provide to recipients of a prescription drug in shortage the sales price for such drug at the time of its sale and at the time of any prior sale of such drug when it was in shortage.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 5853 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus